You are currently not taking any of our courses.
Educate both your staff and your customers with our different courses!
Leveraging EYELID STABILISED design, ACUVUE® OASYS 2-WEEK for ASTIGMATISM provides clear, stable vision, using four stabilisation zones with the lids to help keep the lens in place, even with eye or head movements.1
HYDRACLEAR® PLUS Technology embeds a wetting agent (Polyvinyl pyrrolidone PVP) that mimics mucins to help maintain a stable tear film.4
ACUVUE® RevitaLens Multi-Purpose Disinfecting Solution, a great match with ACUVUE® OASYS with HYDRACLEAR® PLUS 2-week contact lenses7,8,9 – it’s a tried and tested combination you and your patients can rely on8,10,11 for exceptional disinfection7,8,9 and all-day comfort.12
8.6 mm base curve/14.5 mm diameter
Power ranges:
Low minus power range:
Plano to -6.00D (0.25D steps)
CYL: -0.75, -1.25, -1.75, -2.25, -2.75
AXIS: 10° to 180° (10° increments)
High minus power range:
-6.50D to -9.00D (0.50D steps)
CYL: -0.75, -1.25, -1.75, -2.25, -2.75
AXIS: 10° to 180° (10° increments)
Plus power range:
+0.25D to +6.00D (0.25D steps)
CYL: -0.75, -1.25, -1.75, -2.25, -2.75
AXIS: 10° to 180° (10° increments)
2-week replacement (for daily wear)
EYELID STABILISED design is based on a four-zone stability system that utilises positive eyelid interaction by harnessing the power of the eye blink.1
HYDRACLEAR® PLUS Technology embeds tear-like molecules (PVP) that mimic the mucins found in the tear film to help support a stable tear film4
Packing solution contains boric acid and disodium tetraborate (sodium borate) to control the pH of the solution.
‡ www.clinicaltrials.gov is a website maintained by the NIH. Since February 2007, 29 clinical studies evaluated subjective comfort as a primary or secondary endpoint for ACUVUE® OASYS Brand families of contact lenses vs. competitors’ products. Review conducted as of April 30, 2024.
* Source Euromonitor International Limited; Eyewear 2025 edition; value sales at rsp, all retail channels, 2023 data.
1. JJV Data on File 2024, ACUVUE® Brand Contact Lenses for ASTIGMATISM overall fitting success, orientation position, rotational stability and vision performance.
2. JJV Data on file October 2023. Proportion astigmats accommodated with ACUVUE® Brand CLs for ASTIGMATISM.
3. JJV Data on File 2019. Material Properties for Reusable Toric Contact Lenses, Including ACUVUE® OASYS Brand Contact Lenses for ASTIGMATISM and ACUVUE® VITA® Brand Contact Lenses for ASTIGMATISM.
4. JJV Data on File 2018. Similarities between Mucin and Poly(N-Vinyl Pyrrolidone) (PVP).
5. JJV Data on File 2016. 30-day dispensing evaluation, monthly replacement DW study, n=533 soft silicone hydrogel contact lens wearers in the U.S.
6. JJV Data on File 2017. 30-day dispensing evaluation, monthly replacement DW study, n=226 soft toric CL wearers in the U.S. 7. Berntsen DA, Hickson-Curran SB, Jones LW, et al. Subjective Comfort and Physiology with Modern Contact Lens Care Products. Optom Vis Sci. 2016,93(8):809-819.
8. JJV Data on File 2017. Multi-center 1-month dispensing daily wear study with senofilcon C toric contact lenses with RevitaLens OcuTec MPDS, worn for 30 days, n=130 habitual soft toric contact lens wearers in US.
9. JJV Data on File 2016. Multi-center 1-month dispensing daily wear study with comfilcon A toric using RevitaLens OcuTec MPDS, n=95 habitual soft toric contact lens wearers in the US.
10. JJV Data on File 2017. RevitaLens OcuTec MPDS compatibility and clinical performance with ACUVUE® Brand Contact Lenses (2-week daily wear study with senofilcon A, etafilcon A & galyfilcon A, n=203 habitual soft contact lens wearers; 1-month daily wear study with senofilcon C toric contact lenses, N=130 habitual soft toric contact lens wearers, in-vitro laboratory E® evaluations with ACUVUE Brand reusable contact lens materials).
11. JJV Data on File 2012-2015. Laboratory evaluations with RevitaLens OcuTec MPDS and reusable contact lens materials (senofilcon A, senofilcon C, etafilcon A & galyfilcon A).
12. JJV Data on File 2018. ACUVUE® RevitaLens Multipurpose Disinfecting Solution Packaging Claims
Important Safety Information: ACUVUE® Contact Lenses are indicated for vision correction. As with any contact lenses, eye problems, including corneal ulcers, can develop. Some wearers may experience mild irritation, itching or discomfort. Contact lenses should not be used in case of eye infections or any other eye conditions, or in case of a systemic disease that may affect the eye. For detailed product information, including contraindications, precautions and adverse reactions, please consult the Instructions for Use available on Johnson & Johnson website www.e-IFU.com.
2024PP15697
Lens material | senofilcon A |
Technology |
HYDRACLEAR® PLUS EYELID STABILISED Design |
Dk/t (boundary- and edge- corrected)◊3 |
129 x 10-9 |
Water Content | 38% |
UV-blocker**3 | Class 1 |
Centre thickness at -3.00D (mm) | 0.08 |
Inside-out Mark |
No |
Visibility Tint | Yes |
Package Size | 6 lenses |
Packing solution contains boric acid and disodium tetraborate (sodium borate) to control the pH of the solution.
◊ Oxygen is only one of several factors related to maintaining overall eye health when wearing contact lenses
‡ www.clinicaltrials.gov is a website maintained by the NIH. Since February 2007, 29 clinical studies evaluated subjective comfort as a primary or secondary endpoint for ACUVUE® OASYS Brand families of contact lenses vs. competitors’ products. Review conducted as of April 30, 2024.
* Source Euromonitor International Limited; Eyewear 2025 edition; value sales at rsp, all retail channels, 2023 data.
1. JJV Data on File 2024. ACUVUE® Brand Contact Lenses for ASTIGMATISM overall fitting success, orientation position, rotational stability and vision performance.
2. JJV Data on file October 2023. Proportion astigmats accommodated with ACUVUE® Brand CLs for ASTIGMATISM.
3. JJV Data on File 2019. Material Properties for Reusable Toric Contact Lenses, Including ACUVUE® OASYS Brand Contact Lenses for ASTIGMATISM and ACUVUE® VITA Brand Contact Lenses for ASTIGMATISM.
4. JJV Data on File 2018. Similarities between Mucin and Poly(N-Vinyl Pyrrolidone) (PVP).
5. JJV Data on File 2016. 30-day dispensing evaluation, monthly replacement DW study, n=533 soft silicone hydrogel contact lens wearers in the U.S.
6. JJV Data on File 2017. 30-day dispensing evaluation, monthly replacement DW study, n=226 soft toric CL wearers in the U.S. 7. Berntsen DA, Hickson-Curran SB, Jones LW, et al. Subjective Comfort and Physiology with Modern Contact Lens Care Products. Optom Vis Sci. 2016,93(8):809-819.
8. JJV Data on File 2017. Multi-center 1-month dispensing daily wear study with senofilcon C toric contact lenses with RevitaLens OcuTec MPDS, worn for 30 days, n=130 habitual soft toric contact lens wearers in US.
9. JJV Data on File 2016. Multi-center 1-month dispensing daily wear study with comfilcon A toric using RevitaLens OcuTec MPDS, n=95 habitual soft toric contact lens wearers in the US.
10. JJV Data on File 2017. RevitaLens OcuTec MPDS compatibility and clinical performance with ACUVUE® Brand Contact Lenses (2-week daily wear study with senofilcon A, etafilcon A & galyfilcon A, n=203 habitual soft contact lens wearers; 1-month daily wear study with senofilcon C toric contact lenses, N=130 habitual soft toric contact lens wearers, in-vitro laboratory E® evaluations with ACUVU Brand reusable contact lens materials).
11. JJV Data on File 2012-2015. Laboratory evaluations with RevitaLens OcuTec MPDS and reusable contact lens materials (senofilcon A, senofilcon C, etafilcon A & galyfilcon A).
12. JJV Data on File 2018. ACUVUE® RevitaLens Multipurpose Disinfecting Solution Packaging Claims
Important Safety Information: ACUVUE® Contact Lenses are indicated for vision correction. As with any contact lenses, eye problems, including corneal ulcers, can develop. Some wearers may experience mild irritation, itching or discomfort. Contact lenses should not be used in case of eye infections or any other eye conditions, or in case of a systemic disease that may affect the eye. For detailed product information, including contraindications, precautions and adverse reactions, please consult the Instructions for Use available on Johnson & Johnson website www.e-IFU.com.
2024PP15697